The National Psychedelics Association (NPA) is completing Phase 1 of its three-phase launch plan. Starting in 2019 we committed to deep listening with communities, legislators, current/future practitioners, therapists, clinical psychologists, psychiatrists, and leaders of supporting industries. We understand there are critical factors left unaddressed in our collective missions’ to aid the health, wellness and growth of humankind. With this knowledge we are creating the products, services and infrastructure essential to safe, consistent, integrated, non-prescription therapies across the United States.

Through June 2022, the NPA will be conducting Phase 2 – finalizing its products and partnerships, including a proprietary assessment and matching system within the Maya Real World Evidence platform. During this time, we will also begin identifying the board of directors, representative of the United State’s diverse communities.

In late 2022, the NPA will begin Phase 3. In advance of Oregon’s Psilocybin Services Program, we will be providing training organizations, facilitators in training, and service centers with financial/business resources, standards, best practices, integration with wrap-around services, insurance, and industry networking.